carbamates has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahadduri, P; Chang, C; D'Souza, VM; Ekins, S; Johnston, JS; Ray, A; Swaan, PW | 1 |
| Daelemans, D; Delang, L; Grabner, M; Helsen, N; Neyts, J; Scheers, E; Vanstreels, E; Verfaillie, C; Verpaalen, B | 1 |
2 other study(ies) available for carbamates and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
| Article | Year |
|---|---|
In vitro and pharmacophore-based discovery of novel hPEPT1 inhibitors.
Topics: Animals; Aspartame; Carbamates; Cell Line; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Databases, Factual; Dipeptides; Drug Design; Fatty Acids, Monounsaturated; Fluvastatin; Indoles; Ligands; Models, Molecular; Molecular Conformation; Peptide Transporter 1; Piperidines; Protein Binding; Structure-Activity Relationship; Symporters | 2005 |
Understanding the molecular mechanism of host-based statin resistance in hepatitis C virus replicon containing cells.
Topics: Anticholesteremic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbamates; Cell Line, Tumor; Drug Resistance, Viral; Enzyme Activation; Fatty Acids, Monounsaturated; Fluvastatin; Gene Expression Regulation; Hepacivirus; Hepatocytes; Host-Pathogen Interactions; Humans; Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; Imidazoles; Indoles; Oligopeptides; Pyrrolidines; Replicon; Signal Transduction; Valine; Viral Proteins; Virus Replication | 2015 |